Cancer genomics is the study of the totality of DNA sequence and gene expression differences between tumour cells and normal host cells. It aims to understand the genetic basis of tumour cell ...

A new few-shot learning framework called scCAPReSE detects large-scale genomic rearrangements in single-cell Hi-C data using ...

Hologic has signed a definitive agreement to acquire Reveal Genomics, a Barcelona-based precision oncology company developing ...

A prospective trial found constitutional pathogenic variants in about 10 percent of solid tumor patients screened through ...

10x Genomics, Inc. TXG recently announced a multi-project research collaboration with Fred Hutchinson Cancer Center to advance single-cell and spatial technologies across solid tumors and blood ...

CLEVELAND, Ohio — A genomic test used to assess prostate cancer risk may also help doctors determine which patients are ...

The initiative represents the first time 10x Genomics widened its scope past solid tumours to include haematologic malignancies.

PHILADELPHIA & CARLSBAD, Calif., January 08, 2026--(BUSINESS WIRE)--Fox Chase Cancer Center and Arima Genomics, Inc., a company leveraging whole-genome sequence and structure information to provide ...

At the Big Ten CRC Summit, VK Gadi, MD, PhD, explained why functional drug testing and genomic profiling should be used ...

OPTIMA shows Prosigna assay can help many ER-positive, HER2-negative breast cancer patients safely avoid chemotherapy.

Hiroshima University researchers have developed a practical framework to identify candidate pathogenic variants hidden among the large number of variants of uncertain significance (VUS) detected in ...

For two decades, cancer genomic data has underpinned many of the most important discoveries in cancer genomics. However, most studies have relied primarily on whole-exome sequencing (WES), which ...